NEURO

The guidelines recommend that patients with MS receive their recommended vaccines, including that for yearly influenza. Additionally, they noted that no evidence exists that suggests vaccination increases the risk of MS exacerbation. from Front page feed https://ift.tt/2UJoy2e

A boy diagnosed with glycine encephalopathy in the newborn period was initiated on the ketogenic diet at 11 years-old for the treatment of medication refractory epilepsy. from Front page feed https://ift.tt/2UKtnIG

After being approved in Japan in 2013, the selective adenosine A 2A receptor antagonist was given the OK as an add-on to levodopa/carbidopa treatment in adults with Parkinson disease. from Front page feed https://ift.tt/34ufOSf

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Reisa Sperling, MD. from Front page feed https://ift.tt/2Pmf0uY

Jeffrey Dayno, MD, chief medical officer of Harmony Biosciences, as well as John C. Jacobs, the chairman and CEO, shared their insight into the potential impact pitolisant can make in the treatment of narcolepsy and excessive daytime sleepiness. from Front page feed https://ift.tt/2ZlqgfV

The regulatory agency cited 2 concerns in the complete response letter: the risk of infections related to intravenous infusion ports and renal toxicity. from Front page feed https://ift.tt/2ZmkGZF

The director of the Sleep-Wake Disorders Center at Montefiore Medical Center will offer further insights on narcolepsy at the upcoming International Congress on the Future of Neurology, September 27-28, 2019 in New York City. from Front page feed https://ift.tt/2TPakfZ

A generally healthy, young adult male presents with first generalized tonic-clonic seizure followed by episodes of violent psychosis. from Front page feed https://ift.tt/2ZcjTdP

The new drug application for Libervant is expected to be completed in the fourth quarter of 2019, which if approved, would offer a potentially first in class oral treatment for breakthrough or cluster seizures. from Front page feed https://ift.tt/2YJeYlo

The agency said the gene therapy should remain on the market while it assesses the situation and does not impact their evaluation of data from the human clinical trials. from Front page feed https://ift.tt/2YuElXQ

At least 30% of patients with epilepsy have seizures that are incompletely controlled by medical therapy; thus, nonpharmacological options are important for comprehensive care. from Front page feed https://ift.tt/2ZkoBD2

Your patient asks if a ketogenic diet may reduce her migraines. What will you tell her? from Front page feed https://ift.tt/2Mj1sNC

Epidemiology studies are useful to clinicians because they highlight diagnosis and prescribing patterns, common trends within a disease, and unmet needs. from Front page feed https://ift.tt/2MdcW5n

A 27-year-old man has had right arm numbness for about 2 weeks. What’s in your differential? from Front page feed https://ift.tt/2Y7H58A

For years, study participants had been suffering with migraine symptoms and had failed at least three to five therapies before enrolling in the trial. from Front page feed https://ift.tt/32G2UiY

Although Alzheimer disease is not infectious by any common definition of the term, research over the past 20 years has confirmed long-standing speculation that the molecular mechanism driving neurodegeneration is fundamentally the same in Alzheimer disease and the prototypical infectious proteopathy—prion disease. from Front page feed https://ift.tt/2Y45dIZ

A new treatment for NMOSD has been found to reduce relapse, decrease re-hospitalizations, and hinder the need to treat acute attacks with corticosteroids and plasma exchange. from Front page feed https://ift.tt/2JG1RIx

At the recent American Headache Society meeting, researchers detailed the manifold risks of opioid use in patients with migraine. from Front page feed https://ift.tt/2JFOrMx

The genomic revolution has led to increasing opportunities to address complex neurodevelopmental conditions, taking a genetics-first approach. from Front page feed https://ift.tt/2kfBxLj

The latest advances in diagnosis and treatment are discussed in meeting presentations and recent studies and reviews. from Front page feed https://ift.tt/2GeaGHn